Cancer Weekly articles from October 2004

Cancer Weekly archives from October 2004

Animal models are guiding development of new immunotherapies for cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Animal models are guiding the development of new immunotherapies for cancer. According to recent research published in the Journal of Leukocyte Biology, "Immunotherapy using adoptive cell transfer...

Peloruside A tubulin binding characterized.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The tubulin binding properties of the anticancer agent peloruside have been characterized. "Peloruside A (peloruside), a microtubule-stabilizing agent from a marine sponge, is less susceptible than...

Antibodies in tumor immunotherapy reviewed.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers review antibodies in tumor immunotherapy in a recent issue of Expert Opinion on Biological Therapy. "The role of antibodies as therapeutic cancer vaccines includes two distinct...

Apoptosis induction therapy for breast cancer requires p21 signaling.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Apoptosis induction therapy for breast cancer requires p21 signaling. "Inhibitors of historic deacetylase (HDAC) are considered as potential anticancer agents. We have previously demonstrated that...

Suicide gene therapy containing recombinant viral vector attacks sarcoma.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Suicide gene therapy containing recombinant viral vector attacks sarcoma. "Soft-tissue sarcomas are mesenchymal tumors that respond poorly to systemic chemotherapy. Suicide gene therapy may be an...

Chromosomal translocations involving 6p22 breakpoint identified.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Novel chromosomal translocations in acute myeloid leukemia (AML) have been identified and characterized. "The detection of chromosomal aberrations is essential for the diagnosis and therapy" of...

Study says air worse in smoky bars than on truck-choked roads.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- If you're wondering whether a smoky bar or a city street filled with diesel truck fumes is more harmful to your health, you might want to skip your next happy hour. Smoky bars and casinos have up...

Patients with cardiac RyR defects had general anesthesia without complications.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A recent report describes the use of volatile anesthetics and succinylcholine in patients with cardiac ryanodine receptor defects. According to the report from Finland, "Familial polymorphic...

Rac1 GTPase is a strategic target for tumor elimination.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Rac1 GTPase is a strategic target for tumor elimination. "Hypoxia-induced angiogenesis plays an important role in the malignancy of solid tumors. A number of recent studies including our own have...

Ecopia selects four new compounds for further profiling.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Ecopia BioSciences, Inc., (EIA) announced the results of its discovery team's research over the last 5 months, which has led to the identification of 12 novel compounds. Four of the compounds have...

Understanding biology of AT can lead to greater knowledge of its underlying processes.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Ataxia telangiectasia (AT) causes a variety of problems and results from defects in the response to specific types of DNA damage, researchers say. According to a study from the United States,...

Paired iliac artery stent model helps determine drug-delivery device effect.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A paired iliac artery stent rabbit model allows researchers to determine the effect of a new drug-delivery device. According to a study from France, "Preventing coronary in-stent restenosis is a...

Study finds few health effects on dogs exposed to September 11 terrorist sites.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Search-and-rescue dogs deployed after the 9/11 terrorist attacks suffered cuts and scrapes but no serious short-term effects from exposure to the disaster sites, according to research by the University...

Comparative study released on superficial papillary urothelial carcinomas.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Superficial papillary urothelial carcinomas in 'young' patients had a better prognosis than those in the 'elderly' group, according to new research. According to a study from Italy, "To compare the...

Biologic therapy for brain cancers reviewed.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A reseracher reviews biologic therapy for brain cancers in a recent issue of the Yonsei Medical Journal. According to a study from the United States, "The overall goal of our research projects is...

Decoupling the control of brain cancer cells may lead to better treatments.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- When he's not in the operating room performing surgery, Donald M. O'Rourke, MD, associate professor of neurosurgery at the University of Pennsylvania School of Medicine is fighting brain tumors from the...

European marketing authorization issued for expanded use of Gliadel Wafer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals Inc. (GLFD) announced that its proprietary treatment for brain cancer, Gliadel Wafer (polifeprosan 20 with carmustine implant), has been granted extended marketing authorization...

Orphan drug designation granted for Antineoplastons A10 and AS2-1.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Burzynski Research Institute (BRI) (BZYR) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for its drug candidates Antineoplastons A10 and AS2-1 for the...

Autoantibodies to annexin XI-A, other autoantigens have biomarker potential.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Autoantibodies to annexin XI-A and other autoantigens have potential as biomarker of breast cancer, researchers report. F. Fernandez-Madrid, Wayne State University, and colleagues identified...

Bonefos accepted for filing and granted priority review by FDA.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany (SCH, SHR) announced that Bonefos (clodronate) has been accepted for filing and designated for priority review by the U.S. Food and Drug Administration (FDA). Berlex...

Brachytherapy applicator introduced for treating early-stage disease.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Varian Medical Systems (NYSE: VAR) announced the introduction of a new lightweight applicator for delivering postlumpectomy partial breast irradiation. The Advanced Breast Template System for...

Chemokines linked to breast tumorigenesis.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Several chemokines has been tentatively linked to the pathogenesis of breast cancer. In a recent study, oncologists in Boston examined "the comprehensive gene expression profiles of each cell type...

Dense breast patterns evaluated with other risk factors of cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Cancer epidemiologists in the U.K. "studied breast parenchymal patterns and 13 other potential risk factors for breast cancer in 172 breast cancer cases and 338 age-matched controls in Singapore." ...

Hedgehog signaling pathway is new therapeutic target for breast cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS), a therapeutic drug-development company, announced that a recent journal article demonstrates that the Hedgehog signaling pathway is abnormally elevated in a series of human breast...

IDSI adds VP to commercialize laser mammography in global markets.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems, Inc., (IMDS) announced that Janusz Ostrowski has joined the company (IDSI) as vice president, international sales. Ostrowski will be responsible for implementing and...

Mammaglobin-A vaccine has therapeutic potential.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A mammaglobin-A vaccine has potential as a treatment for certain breast cancers, results from a study in mice suggest. The breast cancer-associated antigen mammaglobin-A has been found in 80% of...

Meta-analysis supports IGF-I and IGFBP-3 level link with premenopausal cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Results of a meta-analysis suggest an association between levels of insulin-like growth factor (IGF)-I and IGF-binding proteins and development of premenopausal breast cancer. "IGFs are peptide...

New test discovers breast cancer at early, most treatable stage.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Doctors may soon have a new tool - a noninvasive, painless nipple fluid test - in their fight to make breast cancer a more treatable, nonfatal disease. Within the next couple years, women will be...

Noninvasive breast fluid tests aim to detect disease at most treatable stage.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Two companies are participating in the race to develop a screening technique for early-stage breast cancer based on testing breast fluid. IMI International Medical Innovations, Toronto, Canada, has...

Prolactin acts as a potent survival factor for human cell lines.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The protein hormone prolactin, associated with stimulating lactation, protects human breast cancer cell lines from apoptosis, researchers in the U.K. report. Citing a large epidemiologic study of...

RNA inhibition counteracts the growth of human mammary tumor xenografts.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- RNA inhibition counteracts the growth of human mammary tumor xenografts. According to a study from Austria, "colony-stimulating factor (CSF)-1 is the primary regulator of tissue macrophage...

The cyclooxygenase-2 inhibitor SC-236 stops mammary tumor metastasis.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The cyclooxygenase-2 inhibitor SC-236 stops mammary tumor metastasis. "Cyclooxygenase-2 (COX-2) expression is increased in breast cancer and surgery has been shown to increase the growth of...

U.S. FDA grants review of post-tamoxifen drug for early breast cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Novartis Oncology announced that its supplementary new drug application for Femara (letrozole) has been granted priority review by the U.S. Food and Drug Administration (FDA) for an indication in the...

Intrapleural prosthesis resolves post-pneumonectomy pneumothorax.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- An intrapleural prosthesis can be used to resolve post-pneumonectomy pneumothorax. "Postpneumonectomy syndrome is defined as an airway obstruction due to mediastinal shift and rotation after...

Financial results, clinical pipeline update provide by pharma company.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CATG) announced financial results for the 9 months ended June 30, 2004, a business update for the period since the interim results on May 17, 2004, and a clinical pipeline...

Endoscopy company comments on Israeli Health Ministry committee report.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Given Imaging, Ltd., (GIVN) commented on a report issued by a committee appointed by the Israeli Ministry of Health to investigate the death of an Israeli patient several days following his ingestion of...

Enterprise renames itself.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- PhytoMedical Technologies, Inc., (PYTO), has successfully completed its name change from Enterprise Technologies, Inc. The new name more accurately reflects the company's entry into the research,...

MastaScope Mammary Ductoscopy System to be distributed in China.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Lifeline Biotechnologies, Inc., (LBTT) has entered into a 4-year contract with International Medical Consulting Group (IMCG) of Dallas, Texas, for its Chinese company, Shanghai Science Medical...

"Pill camera" to be developed to detect cancer, monitor body functions.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Infotonics Technology Center and Medi-photonics Development Company LLC announced their intent to agree to jointly develop the Compact Photonic Explorer (CPE), or "pill camera," for medical and...

MMA may result in 43%-54% loss in community-based cancer care funds in 2005.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- At a Congressional briefing on Capitol Hill, the American Society of Clinical Oncology (ASCO) released findings from an analysis of the effect of the Medicare Modernization Act (MMA) on cancer care in...

PSA era is over for predicting prostate cancer risk, say Stanford researchers.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine...

Phase I study of TNFerade for soft tissue sarcoma published.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (NASDAQ:GNVC) announced that results from a phase 1 study for its lead product candidate, TNFerade, in patients with soft tissue sarcoma of the extremities were published in the Clinical...

Tailored counseling may promote mammography among low-income rural black women.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Low-income older black women in rural areas of Arkansas who had never had a mammogram were more likely to do so after receiving a call from a community healthcare worker, University of Arkansas public...

Computationally predicted nucleotides halt bladder and breast cancer growth.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Computationally predicted nucleotides halt bladder and breast cancer growth. According to recent research published in the journal Cancer Letters, "angiogenesis plays a key role in tumor growth and...

Lats2 boosts tumor apoptosis by down-regulating Bcl-2 and Bcl-x(L).
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Lats2 boosts tumor apoptosis by down-regulating Bcl-2 and Bcl-x(L). "Lats2, also known as Kpm, is the second mammalian member of the novel Lats tumor suppressor gene family. Recent studies have...

Double drug combo attacks tumor and blood vessel development.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Cancer researchers have long suggested that new targeted drugs may work best when paired with other therapies. In a new study published in Cancer Research, scientists have taken some of the first...

Gene therapy for bladder cancer shows strong results in animal studies.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Gene therapy that causes the bladder to act like a "bioreactor" to produce and secrete the anticancer agent interferon-alpha has shown dramatic benefits in preclinical tests, say researchers at The...

Novel tumor antigen may be useful in osteosarcoma immunotherapy.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A novel tumor antigen may be useful in osteosarcoma immunotherapy. According to recent research from Japan, the "prognosis for patients with osteosarcoma who do not respond to current chemotherapy...

Pharma company finds anticancer drug effective in reducing tumor size.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Solbec Pharmaceuticals Ltd (ASX:SBP) announced that its anticancer drug SBP002 was effective in reducing tumor size in some patients involved in a phase I trial, and have requested to continue taking...

Radiation therapy center operator announces financing deal.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- OnCURE Medical Corp. (OnCURE) announced that it has completed a $15 million debt financing to fund future acquisitions and restructure its existing line of credit and other debt. Approximately $7...

Radiation therapy management company expands into New Jersey.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced that it has entered into definitive purchase agreements to acquire three radiation centers in New Jersey, which currently treat more than 60...

Successful pre-IND meeting for AVR118 with FDA reported.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company had a successful pre-investigational new drug (IND) meeting with the U.S. Food & Drug Administration (FDA) at the end of August. ...

Afraid that cancer will return, doctors treat "cure" like a four-letter word.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- There wasn't any doubt 6 years ago that Doug Jensen had cancer. The Oregon engineer's blood was clogged with the immature cells that are sure signs of leukemia. Treatment with a new wonder drug,...

Dendritic cell-based immunotherapy for cancer reviewed.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers review dendritic cell-based immunotherapy for cancer in a recent issue of Transfusion Medicine Reviews. According to recent research from the United States, "The encouraging results...

Gene-engineered T cells are superior adjuvant therapy for cancer.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Gene-engineered T cells are a superior adjuvant therapy for metastatic cancer. According to a study from Australia, "The major limiting factor in the successful application of adjuvant therapy for...

Heat shock proteins reviewed.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers review heat shock proteins in a recent issue of Immunology Letters. "The contribution of major histocompatibility complex (MHC) I and II to the adaptive immune response has been well...

Strategies to improve dendritic cell cancer immunotherapy outlined.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers outline strategies to improve dendritic cell-based immunotherapy against cancer in a recent issue of the Yonsei Medical Journal. "Dendritic cells (DCs) play a pivotal role in T...

Ubiquitin-fusion degradation pathway plays key role in DNA vaccination.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent...

Yeast-based immunotherapy causes mutation-selective tumor remission.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Ras-targeted, whole yeast-based immunotherapy resulted in mutation-selective tumor remission. "Activating mutations in Ras oncoproteins represent attractive targets for cancer immunotherapy, but...

COUP-TFII encourages lung cancer cell invasion.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- COUP-TFII encourages lung cancer cell invasion. According to a study from Canada, "chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) plays an essential role in angiogenesis...

DMBA-induced mammary tumor progression depends on VEGF-dependent angiogenesis.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- DMBA-induced mammary tumor progression depends on VEGF-dependent angiogenesis. According to a study from the United States, "preinvasive mammary pathologies in humans and rat chemical carcinogenesis...

Defective gene thwarts cell talk, leading to breast and ovarian cancers.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Scientists have recently discovered that the gene EDD is implicated in the development of breast and ovarian cancer. "Cancer arises from defects in cell growth and division. We are now beginning to...

Stromal bradykinin B-2 receptor signals foster tumor growth and angiogenesis.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Stromal bradykinin B-2 receptor signals foster tumor growth and angiogenesis. "We evaluated the significance of the host kallikrein-kinin system in tumor angiogenesis and tumor growth using two...

Alemtuzumab may have a role in inducing important cardiac side effects.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sezary syndrome "Alemtuzumab is a monoclonal antibody to CD52 that has activity in T-cell leukemia and lymphoma. This study alms to...

Development of therapeutic nucleic acids is ongoing.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers with the U.S. National Cancer Institute recently provided an overview on the development of therapeutic nucleic acids to target cervical cancer. "Cervical cancer is the second most...

Interlaboratory results support Hybrid Capture 2 HPV test's reliability.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Interlaboratory results show Digene's Hybrid Capture 2 test is reliable for detecting human papillomavirus DNA in liquid cytology specimens. Researchers at the U.S. National Cancer Institute and at...

Mathematical model supports U.K. screening interval recommendations.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A mathematical model of cervical human papillomavirus infection and cancer in the U.K. supports recently revised cervical cancer screening interval recommendations. According to a paper published...

Non-European HPV type 16 variants more frequent in invasive disease.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- A study from Italy found non-European variants of human papillomavirus type 16 occurred more frequently in invasive cervical cancer lesions than European variants. "Human papillomavirus type 16...

Study reports "pronounced" chromosomal instability in advanced disease.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Biophysicists in Norway report finding "pronounced" chromosomal instability in advanced cases of cervical cancer. "Intratumor heterogeneity in chromosomal aberrations is believed to represent a...

Upregulation of uPA by HER-2/neu appears to occur in early stage disease.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Upregulation of urokinase plasminogen activator by the HER-2/neu oncogene appears to occur in the early stage of cervical cancer in patients, according to recent research. "It has been suggested...

Overexpressed dominant-negative FANCA helps cisplatin battle tumors.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Overexpressed dominant-negative FANCA helps cisplatin battle tumors. "Fanconi anemia (FA) is a rare genetic disorder characterized by bone-marrow failure and cellular hypersensitivity to...

The flagellar motor controls exopolysaccharide expression in V. cholerae.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- There is a complex relationship between the flagellum-dependent exopolysaccharide (EPS) signaling cascade and virulence in a mouse model. According to recent research published in the Journal of...

Companies initiate phase IIIb clinical trial of Tarceva in advanced NSCLC.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and OSI Pharmaceuticals, Inc., (OSIP) announced the initiation of a phase IIIb clinical study of the investigational therapy Tarceva (erlotinib HCl) in patients with second- and...

Alliance to discover, develop multiple small molecule oncology products.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., and Biogen Idec (BIIB) announced a collaboration to discover and develop small molecule cancer therapeutics targeting kinases, a family of cell signaling enzymes that play...

Diagnostics company enters broad diagnostic collaboration with Compugen.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Diagnostic Products Corp. (DP) and Compugen, Ltd., (CGEN) announced a broad collaboration for the development and commercialization of novel diagnostic products, with an anticipated focus in the cancer...

Combination gene therapy reduces murine colon cancer cell growth.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Combination gene therapy reduces murine colon cancer cell growth. "We evaluated the antitumor effects of combination gene therapy on CT26 mouse colon cancer cells, using the genes for herpes...

Positive results reported on colon cancer using its RECAF blood test.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- BioCurex, Inc., (BOCX.PK) reported positive detection results for an additional type of cancer using its RECAF based blood test. Seventy-three samples from patients with colon cancer were compared...

Strong association of ARK5 with tumor invasion and metastasis.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- There is a strong association of ARK5 with tumor invasion and metastasis. According to a study from Japan, "We recently identified a novel human AMPK family member, ARK5, and discovered that is a...

Use of iron deficiency test as colorectal cancer screen feasible.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- The use of an iron deficiency test as a colorectal cancer screen is feasible, although the benefit may be marginal. "Iron deficiency is common at presentation in colorectal cancer," physicians in...

Colorectal neoplasm preoperative tattooing reliable for laparoscopic resection.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Researchers from New York City reported that preoperative endoscopic tattooing of colorectal neoplasms is generally a safe and reliable method of tumor localization in laparoscopic resection. ...

Defective CD34+ progenitors compromise myelodysplastic syndrome therapy.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Defective CD34+ progenitors compromise myelodysplastic syndrome therapy. "The in vivo effect of recombinant human erythropoietin (rHuEpo) and granulocyte colony-stimulating factor (G-CSF) combined...

Study found no regrets among parents who talked to their dying children about death.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Should parents talk to their dying children about death? A Swedish study found that parents whose children died of cancer had no regrets about talking to them about death, while some who didn't do...

Direct protein microarray detection strategies reviewed.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Scientists review direct protein microarray detection strategies in a recent issue of the Journal of Immunological Methods. "Protein microarrays are being utilized for functional proteomic...

Minimal residual disease assessment predicts survival and relapse in AML.
October 5, 2004... 2004 OCT 5 - (NewsRx.com & NewsRx.net) -- Minimal residual disease assessment predicts survival and relapse in acute myeloid leukemia. "Outgrowth of minimal residual disease (MRD) in acute myeloid leukemia (AML) is responsible for the...